Endogenous mouse mammary tumor virus genomes are amplified and located in novel cell DNA sequences in many mouse T-cell lymphomas. Transplanted tumors recovered from the same mouse strain and shown to be of independent origin by chromosomal analysis, by the presence of JH immunoglobulin gene rearrangements, or by the integration patterns of exogenous Moloney MuLV genomes frequently showed similar patterns of novel mouse mammary tumor virus-containing cell DNA fragments. This process of amplification and relocation can occur within a limited number of cell generations and in C57BL/6 mice does not lead to the synthesis of mature virus-encoded proteins. In some instances, amplified mouse mammary tumor virus genomes contained novel restriction cleavage sites in the gag-pol region. The restricted time course of occurrence, lack of synthesis of mature virion proteins, and apparent site specificity indicate that this process of retrovirus amplification differs significantly from virus replication after exogenous infection.
The chromosomal and phenotypic instability of tumor cells is a well-documented phenomenon, and several investigators have emphasized the importance of this instability for the emergence of cell populations with increased growth and metastatic potential (28) . Although many investigations have emphasized the individually specific nature of chromosomal abnormalities, it is well established that different tumors of leukocyte origin, e.g., Burkitt's lymphoma, human myelocytic leukemia, T-cell leukemias, and plasmacytomas, each show characteristic common patterns of chromosomal abnormalities. Molecular changes identified include the chromosomal translocations involving the c-myc oncogene and the immunoglobulin a heavy-chain locus (9, 30, 46) , amplification of c-myc in a human myeloid leukemia (7, 11) , translocation of c-abl in the Philadelphia chromosome of chronic myelocytic leukemia (12) , and rearrangement of cmos in a Burkitt's lymphoma and in a mouse myeloma (38) . In the present study, we examined the DNA of several mouse lymphomas for evidence of changes in the number and positions of a class of endogenous retroviral genomes, the mouse mammary tumor viruses (MMTV).
Endogenous proviruses of MMTV behave as stable genetic elements in inbred strains of mice (6, 23, 50) . These proviruses occur in multiple copies in the DNA of most inbred mice and are found on several different chromosomes (32, 50) . Little is known about the biological activity of the endogenous MMTV genomes found in C57BL/6(B6), A/J, and BALB/c mice, although activation of MMTV in BALB/c mice has been observed (23) . MMTV recovered from the milk of C3H and GR mice (milk-borne or exogenous virus) induce mammary carcinomas (23) . A virus similar to milkborne MMTV is also transmitted in the germ line of C3H and GR mice and is genetically distinguishable by restriction endonuclease polymorphisms from endogenous MMTV found in other inbred strains, e.g., B6, A/J, and BALB/c (5, 6) (Fig. 1) .
We observed that endogenous MMTV genomes are frequently amplified in several transplantable T-cell lympho- (26) . The distances given here are approximate and have been calculated from data by Cohen and Varmus (6) and Kennedy et al. (26) . Probes used in this study correspond to the exogenous virus PstI-A gag-pol fragment, the PstI-B env fragment, and the PstI-C LTR fragment. The mouse strains B6, BALB/c, and A/J also appear to contain unit I (not shown), a poorly characterized provirus with a minimum complexity of 3.2 kbp (6).
manufacturer. Completeness of enzyme digestions was monitored in parallel reactions by inclusion of a marker with known digestion characteristics. Digestions judged complete by this assay were run on 0.7 to 0.8% horizontal agarose gels containing 50 mM Tris-hydrochloride, pH 8.05, 20 mM sodium acetate, and 2 mM EDTA (22) , stained with ethidium bromide, and transferred to nitrocellulose (48) using 1Ox SSC (lx is 0.15 M NaCl plus 15 mM sodium citrate).
Preparation of hybridization probes. The cloned PstI fragments of the C3H strain of MMTV (PstI-A, PstI-B, and PstI-C) and the MMTV 4-la clone were obtained from J. Majors, University of California, San Francisco (17; J. Majors, unpublished data). The MMTV 4-la clone was derived by cleavage of MMTV supercoiled DNA at the single EcoRI site and ligation into the vector XgtWESXB (J. Majors, unpublished data). This clone has a rearranged PstI map but clearly detects all internal PstI fragments described by Cohen and Varmus (6) (for example, see Fig. 5A , lane 6). MMuLV-specific clones (52) were kindly provided by I. Verma, Salk Institute, La Jolla, California. The JlJ2 and mu clones were obtained from J. Richards and F. Blattner (33) . The plasmid DNA, containing a BamHI-PstI fragment of the intervening sequence for 3-major globin, was provided by A. Kinniburgh. The a-casein plasmid DNA was a gift of J. Rosen (44) . The cloned DNA specific for the Abelson leukemia virus was provided by B. Dale and B. Ozanne (10) .
Recombinant plasmids in Escherichia coli HB101 were grown and purified as previously described (17) except that plasmid DNA was digested sequentially with RNase and proteinase K after CsCl-PI, gradients.
32P-labeled hybridization probes were prepared by nick translation as described by Rigby et al. (39) . Specific activities were usually 1 x 108 to 5 x 108 cpm/pLg.
Hybridization conditions. Southern blots were prehybridized for 12 to 18 h in buffer A containing 50% formamide, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.4, 2x Denhardt solution (14) , 0.4% sodium dodecyl sulfate, 3x SSC, 500 ,iLg of yeast RNA per ml, and 100 ,ug of salmon sperm DNA per ml at 41°C. Subsequently, excess buffer was removed and replaced by 5 x 106 cpm of heat-denatured probe in 2 ml of buffer A, and the mixture was incubated at 41°C for 48 to 72 h. Filters were washed and dried as described by Payne et al. (37) and exposed to Kodak XAR-5 film in the presence of intensifying screens (Dupont Lightning Plus) at -70°C (49) . Filters used for rehybridization were placed in 10 ml of buffer A inside airtight plastic bags and heated to 68°C for 30 min. The eluate was removed, and the procedure was repeated once before filters were prehybridized and hybridized as described above.
Cytotoxicity and rosetting assays. Conditions for cytotoxicity assays and absorption tests have been described (42) . Rosetting assays were performed by the method of Scheid and Triglia (45) .
Chromosome analysis. Slides of metaphase chromosomes were prepared as previously described (25) (52) . To determine whether the sites of integration of M-MuLV genomes were identical in these two tumor lines, we hybridized the filter shown in Fig.  2A to a cloned probe specific for the LTR region of MMuLV (Fig. 2B ). The presence of novel M-MuLV-hybridizing EcoRI fragments of greater than 8.8 kbp (genome length) in P3C and RBL-5B indicates that these tumors were derived from independent infection events (lanes 1 and 3). In agreement with previous studies, additional subgenomic fragments of similar size were observed in virus-induced tumors; their origin is unknown (52) . Tumors induced by chemicals, e.g., EL4, or radiation, e.g., ERLD (18, 19, 35) , contained no M-MuLV sequences (Fig. 2B, lanes 2 and 4) .
Chromosome analysis by quinacrine staining (B. Kahan, unpublished data) supports the contention that EL4 is distinct from the other two tumors. Examination of metaphase preparations of EL4 cells revealed one metacentric and one small telocentric chromosome, each of which was clearly different from the 40 telocentric chromosomes of the normal mouse karyotype. Both of these markers are absent from the P3C line, which contained additional marker chromosomes, including a metacentric, a submetacentric, and a long telocentric chromosome. These abnormal chromosomes are absent from the EL4 line. The RBL-5B line contains some marker chromosomes similar or identical to those of the P3C line in addition to other unique chromosomes.
Finally, RBL-5B cells can be distinguished from the other tumors by the presence of a novel DNA fragment containing sequences from the JH immunoglobulin gene region. Several lymphoid tumors of T-and B-cell origin have been reported to contain altered heavy-chain JH regions (8) . To identify such rearrangements, B6 tumor DNAs were digested with EcoRI and hybridized to a cloned probe that contained the J1J2 region of the heavy-chain locus (Fig. 2C) . A novel ca.
4-kbp fragment was detected in the RBL-5B cell line (lane 4) in addition to the germ line fragment of 6.2 kbp. Digestion of these DNA samples with the enzymes HindlIl and XbaI followed by hybridization with the J1J2 probe yielded novel fragments of 2.9 and 1.9 kbp, respectively, in addition to that found in germ line DNA. Thus, each of these tumor lines bears two or three intrinsic markers that distinguish them from each other, although their pattern of amplified MMTV genomes is similar.
The DNA samples from lymphoid tumors of three other inbred mouse strains, BALB/c, AKR, and A/J, were examined for the presence of amplified MMTV genomes. DNA samples were cleaved with the enzyme EcoRI, subjected to Southern blot analysis, and hybridized to a nick-translated probe for the MMTV LTR (PstI-C) (Fig. 3) . The pattern typical of normal BALB/c DNA is shown in Fig. 3 , lane 1 (6) . additional MMTV-hybridizing fragments (see Fig. 5 ). The hybridization patterns in Fig. 3 To determine whether the 4.5-kbp fragment present in B6 tumor DNA represents the gag-pol region of the viral genome or a viral-cellular DNA junction fragment, a second parallel filter was hybridized to a probe specific for the PstI A gag-pol fragment ( It is possible that most of the novel restriction fragments detected in tumor DNA cut with single-hit enzymes result from internal rearrangements of viral sequences other than the gag-pol region. Therefore, lymphoid tumor DNAs were cleaved with PstI and hybridized to PstI-B env and PstI-C LTR probes (Fig. 5C and D, respectively) .
Inspection of Fig. SC revealed that the major band of hybridization to the PstI-B env probe in all lymphoid tumors was 2.1 kbp in size, indicating little if any rearrangement within this fragment. In contrast, hybridization of the LTR probe to lymphoid tumor DNA (Fig. 5D) 3 and 5) . Longer exposures of this autoradiogram revealed the unit II-and unit III-specific viral-cellular DNA junction fragments. The intensity of the B6 lymphoid tumor 2.1-kbp env band (Fig. SC, lanes 1 through 3) was not as great as the corresponding band in GR tumor DNA (lane 6). This result is consistent with the greater-than-diploid complement of MMTV proviruses in B6 and BALB/c lymphoid tumors, the number of copies being significantly less than that present in GR tumor cells.
These observations indicate that the majority of new MMTV-specific fragments appearing in T-cell lymphoid DNA are associated with the viral LTRs. These new fragments may arise from amplification and rearrangement of the LTRs themselves to generate fragments of greater than 1.4 kbp, which we consider unlikely. Alternatively, the LTRs are in a new context of cellular DNA due to cellular rearrangements or viral reinsertions.
MMTV protein expression not observed in B6 T cell lymphomas. Since MMTV is known to be an oncogenic agent in the mammary gland and since oncogenesis is often accompanied by MMTV protein synthesis (23), we examined lymphomas containing amplified MMTV sequences for the presence of viral proteins. Cells were labeled in the presence of
[35S]methionine, disrupted in a nonionic detergent, immunoprecipitated with MMTV-specific antisera, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analysis of the virus-producer cell line GR was used as a control. Polypeptides typical of MMTV-infected cells were detected readily in the presence and absence of the glucocorticoid dexamethasone. These polypeptides included the presumptive gag-pol precursor of 160,000 Mr, the 110,000 Mr protein, a doublet representing precursors of gag and env (pr78e"' and pr80g0'g), and the major glycosylated protein of 52,000 Mr (15, 17) (Fig. 6) .
The lymphoma B6Mo3 contained little, if any, MMTVspecific polypeptides (Fig. 7, lanes 6 through 9) separate experiments, although polypeptides related to the M-MuLV p15 and gp7O proteins were detectable in this cell line (lanes 10 and 11). Labeling and immunoprecipitation of additional B6 lymphomas which have amplified MMTV sequences demonstrated that these lines also do not show detectable expression of MMTV proteins (data not shown). This level of protein expression is likely to be at least 5-to 10-fold less than that made in GR cells in the absence of dexamethasone. Moreover, MMTV proteins are undetectable by radioimmunoassay in C57BL mammary glands (51) , suggesting that MMTV polypeptide synthesis is restricted in more than one tissue.
The BALB/c T-cell lymphoma line S49G3, previously shown to contain MMTV-specific RNA (41) , also contained MMTV-specific polypeptides (Fig. 7, lanes 1 through 4) . How, then, do novel MMTV proviruses and virus-cell junction fragments arise in these tumors? The obvious explanation of multiple cycles of infection and reintegration of viral genomes seems unlikely due to the absence of virus production or, in most cases, viral proteins in cells with amplified genomes. Exogenous MMTV appears to integrate at random after infection, and massive integration, as seen in GR cells, is not accompanied by the generation of novel restriction sites in the gag-pol region.
Another mechanism to explain changes in MMTV-containing sequences involves amplification and rearrangements in cellular DNA adjacent to endogenous proviruses. Conserved chromosomal amplifications and rearrangements are characteristics of many B-and T-cell tumor lines of mice (8, 53) . In particular, trisomies of chromosome 15 (and more rarely chromosome 17) have been associated with T-cell lymphomagenesis (53) . Such chromosomal rearrangements could account for the novel internal PstI fragments observed in B6 tumors, the EcoRI fragments of less than 4 kbp, as well as variations in restriction fragment intensity (see Fig. 2 ). The translocation of NIARD, i.e., c-myc, sequences to the a-switch region of the heavy-chain locus in immunoglobulin A-secreting mouse plasmacytomas shows site specificity in many tumors (3, 46) . Clearly chromosomal elements with DNA structures similar to proviruses, i.e., moveable genetic elements, can serve as sites for chromosomal change (27 The significance of the changes in the numbers and positions of retroviral genomes found in transplanted tumors for the differentiation or oncogenic phenotype of these cells is unknown. Clearly, these cells represent an extreme in malignant phenotypes, and so the alterations observed here may be purely coincidental. It is equally possible that changes in endogenous retroviral genomes reflect a process, which when concerned with these or other genes, provides the basis for genetic instability and subsequent selection.
